Analgesic effect of oral oxycodone and intravenous fentanyl in patients undergoing colonoscopy

Comparison of analgesic effects of oral oxycodone and intravenous fentanyl in patients undergoing lower gastrointestinal colonoscopy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20111010007752N13

Enrollment

Registered

2022-10-14

Start date

2022-10-02

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain. Other acute postprocedural pain

Interventions

Intervention 1: Intervention group: Patients receive slow-release oral oxycodone (Faroxi company) with a dose of 30 mg one hour before the start of the colonoscopy, then after one hour they enter the

Eligibility

Sex/Gender

All

Age

18 Years to 69 Years

Inclusion criteria

Inclusion criteria: The American Society of Anesthesiologists (ASA) class I&II (Grade 1: No cardiovascular, respiratory, glandular and Grade 2: Controlled diabetes) Age 18-69 years old Colonoscopy candidate Consent to participate in the study

Exclusion criteria

Exclusion criteria: Decreased level of consciousness GCS less than 15 History of drug addiction Hemodynamic instability Mental disorders

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: during colonoscopy. Method of measurement: visual analog scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParviz Amri

Babol University of Medical Sciences

p.amrimaleh@mubabol.ac.ir+98 11 3233 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026